CCL vs MLTX · P/E 15, rev $12.83B vs $1.41B cap
Carnival Corporation (CCL) versus MoonLake Immunotherapeutics (MLTX) — a side-by-side from cached financials, not a winner call.
Carnival Corporation (CCL) is a travel services company listed on US.
MoonLake Immunotherapeutics (MLTX) is a biotechnology company listed on US.
Latest reported CCL revenue for 2026-05-31 was $12.83B. Net income was $795.0M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
MLTX does not have a complete income-statement cache yet.
CCL currently screens at market cap $39.74B and trailing P/E 15.3. MLTX currently screens at market cap $1.41B.
Not investment advice. Open the CCL and MLTX stock pages for the full models.
Not investment advice.